How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations

Abstract

Health technology assessment (HTA) agencies vary in their use of quantitative patient preference data (PP) and the extent to which they have formalized this use in their guidelines. Based on the authors' knowledge of the literature, we identified six different PP “use cases” that integrate PP into HTA in five different ways: through endpoint selection, clinical benefit rating, predicting uptake, input into economic evaluation, and a means to weight all HTA criteria. Five types of insight are distinguished across the use cases: understanding what matters to patients, predicting patient choices, estimating the utility generated by treatment benefits, estimating the willingness to pay for treatment benefits, and informing distributional considerations. Summarizing the literature on these use cases, we recommend circumstances in which PP can add value to HTA and the further research and guidance that is required to support the integration of PP in HTA. Where HTA places more emphasis on clinical outcomes, novel endpoints are available; or where there are already many treatment options, PP can add value by helping decision makers to understand what matters to patients. Where uptake is uncertain, PP can be used to estimate uptake probability. Where indication-specific utility functions are required or where existing utility measures fail to capture the value of treatments, PP can be used to generate or supplement existing utility estimates. Where patients are paying out of pocket, PP can be used to estimate willingness to pay.

Expanding health technology assessment towards broader value: Ireland as a case study

“…From a methodological perspective, patient and public values and preferences for health technologies could be incorporated into HTA through several approaches, including quantifying the domains and harmonizing them into model inputs (39). Stated preferences methods used to study preferences and values for healthcare services, treatments, and outcomes are well-suited to the task, which is essential for translation to HTA.…”

Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods

“…Concerns have been raised on the cognitive burden of certain preference elicitation methods and its effect on the reliability of results [31]. We addressed this limitation by dividing the ranking into three consecutive votes, asking only for the top three of the 9, 6 and 3 value elements, respectively.…”

Pregnant women's and policymakers' preferences for the expansion of noninvasive prenatal screening: A discrete choice experiment approach study

“…2 Having tools that allow the measurement of patient preferences and demands for health and healthcare interventions is valuable for health technology assessment (HTA) agencies. 3 In each HTA agency (e.g., the National Institute for Health and Care Excellence in England and Wales; the United States Food and Drug Administration; and the Canadian Agency for Drugs and Technologies in Health), these inputs are evaluated by appraisal committees before deliberating national recommendations on the offer of a new intervention. The committee members who are referred to as policymakers consist of diverse experts, such as researchers, clinicians, ethicists, managers, and citizens.…”